Summary
The sample “Winimed 10” from DEUS Medical underwent qualitative and quantitative analysis. Testing confirmed the presence of Stanozolol with measured concentrations of 9.55 mg in the first pill and 9.86 mg in the second pill.
Testing was ordered and conducted on 18-20 November 2020.
Detailed Report
Product Overview
- Manufacturer: DEUS Medical
- Product Name: Winimed 10
- Active Ingredient: Stanozolol
- Batch Number: DM69237
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #09127
- Testing Ordered: 18 November 2020
- Sample Received: 18 November 2020
- Analysis Conducted By: Janoshik Analytical
- Submitted By: DEUSPOWER.SHOP
- Analysis Paid For By: DEUSPOWER.SHOP
Testing Results
- Identified Compound: Stanozolol
- First Pill Concentration: 9.55 mg
- Second Pill Concentration: 9.86 mg
Verification Details
- Verification URL: https://janoshik.com/tests/09127_LNP7Z3U51H8Y
Evaluation of Reseller-Submitted Testing
The test confirms the presence of Stanozolol in the Winimed 10 pills with minor dosage variations (9.55 mg and 9.86 mg), which are within acceptable manufacturing tolerances for pharmaceuticals.
Conclusion
The results validate the presence and dosage of Stanozolol in the sample, demonstrating compliance with the expected formulation standards.
Disclaimer
This report is for informational purposes and reflects findings based on reseller-submitted testing. Independent third-party analysis is recommended for thorough validation.
